BNR
Price
$2.90
Change
-$0.04 (-1.36%)
Updated
Jun 6 closing price
Capitalization
74.76M
EFAD
Price
$42.73
Change
+$0.02 (+0.05%)
Updated
Jun 6 closing price
Net Assets
71.12M
Interact to see
Advertisement

BNR vs EFAD

Header iconBNR vs EFAD Comparison
Open Charts BNR vs EFADBanner chart's image
Burning Rock Biotech
Price$2.90
Change-$0.04 (-1.36%)
Volume$21.85K
Capitalization74.76M
ProShares MSCI EAFE Dividend Growers
Price$42.73
Change+$0.02 (+0.05%)
Volume$25.74K
Net Assets71.12M
BNR vs EFAD Comparison Chart
Loading...
EFAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNR vs. EFAD commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNR is a Hold and EFAD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BNR: $2.90)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNR’s FA Score shows that 1 FA rating(s) are green while.

  • BNR’s FA Score: 1 green, 4 red.

Price Growth

BNR (@Medical Specialties) experienced а -6.45% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.46%. For the same industry, the average monthly price growth was +5.98%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BNR is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Medical Specialties (+2.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
EFAD
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 25 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
EFAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMUAX14.52N/A
N/A
Federated Hermes Muni and Stock Adv A
ODINX80.04N/A
N/A
Invesco Discovery R
MSIQX11.67N/A
N/A
Morgan Stanley Inst International Eq I
TGVYX54.23N/A
N/A
Touchstone Dynamic Large Cap Growth Y
UIVQX12.30N/A
N/A
MFS Intrinsic Value R4

BNR and

Correlation & Price change

A.I.dvisor tells us that BNR and ZOMDF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNR and ZOMDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNR
1D Price
Change %
BNR100%
-1.36%
ZOMDF - BNR
28%
Poorly correlated
-2.09%
ZIMV - BNR
28%
Poorly correlated
+2.85%
RVTY - BNR
25%
Poorly correlated
+1.62%
ACRS - BNR
24%
Poorly correlated
-1.92%
SINT - BNR
24%
Poorly correlated
+1.07%
More

EFAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, EFAD has been loosely correlated with LOGI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAD jumps, then LOGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EFAD
1D Price
Change %
EFAD100%
+0.06%
LOGI - EFAD
48%
Loosely correlated
+1.12%
BNR - EFAD
10%
Poorly correlated
-1.36%
UCB - EFAD
8%
Poorly correlated
+2.09%
ROG - EFAD
7%
Poorly correlated
+0.83%
APA - EFAD
6%
Poorly correlated
+3.64%
More